Gabriel Gaspar

TL;DR: The findings suggest that eradication of HCV after therapy with interferon plus ribavirin in HIV/HCV-coinfected patients is associated not only with a reduction in liver-related events but also with a reduced in HIV progression and mortality not related to liver disease.

TL;DR: Simultaneous HAART and TB treatment in HIV patients with TB is associated with improved survival, and ST remained robustly associated withImproved survival after adjusting for other prognostic variables.

TL;DR: In this large real‐world study, direct‐acting antiviral agent–based therapy was safe and highly effective in coinfected patients; predictors of failure included gender, human immunodeficiency virus–related immunosuppression, HCV RNA load, severity of liver disease, and the use of suboptimal direct‐ acting antiviralAgent–based regimens.

TL;DR: The data suggest that eradication of HCV in coinfected patients is associated not only with a reduction in the frequency of death, HIV progression, and liver‐related events, but also with a reduced hazard of diabetes mellitus and possibly of chronic renal failure.

TL;DR: The impact of end-of-treatment response with subsequent relapse (REL) on LR events (LR death, liver decompensation, hepatocellular carcinoma, or liver transplantation), and liver stiffness (LS) by transient elastography is assessed by transientElastography.